|
2021
|
Invention
|
Composition and method for treating neurological disease.
Disclosed are compositions comprising ... |
|
|
Invention
|
Amantadine compositions, preparations thereof, and methods of use. Provided herein are oral pharm... |
|
|
P/S
|
Providing a website featuring information in the field of treatment and management of dyskinesia ... |
|
2020
|
Invention
|
Methods of administering amantadine. Methods of nighttime administration of amantadine to reduce ... |
|
2019
|
Invention
|
Method of administering amantadine prior to a sleep period. Methods of nighttime administration o... |
|
|
Invention
|
Amantadine compositions and preparations thereof. Provided herein are oral pharmaceutical composi... |
|
|
Invention
|
Methods of using amantadine compositions. Provided herein are oral pharmaceutical compositions co... |
|
|
Invention
|
Composition for administering an nmda receptor antagonist to a subject.
The invention provides e... |
|
2018
|
P/S
|
Providing computerized solution-based technologies for the purpose of patient support services to... |
|
|
Invention
|
Amantadine compositions and methods of use.
Methods of nighttime administration of amantadine to... |
|
|
P/S
|
patient assistance program that provides medical drugs to help patients with insufficient resourc... |
|
2017
|
P/S
|
Pharmaceuticals for the treatment of disorders of the central nervous system, namely, Parkinson's... |
|
|
Invention
|
Compositions for the treatment of cns-related conditions.
The invention provides methods for tre... |
|
|
P/S
|
Pharmaceuticals for the treatment of nervous system disorders. |
|
|
P/S
|
Oral pharmaceuticals for treatment of neurological conditions |
|
2015
|
Invention
|
Methods of administering amantadine compositions.
Methods of administration of amantadine to imp... |
|
|
P/S
|
Pharmaceuticals for the treatment of nervous system disorders |
|
|
Invention
|
Composition and method for treating neurological disease. Disclosed are compositions comprising a... |
|
2014
|
Invention
|
Composition and method for treating neurological disease. A method of administering amantadine is... |
|
2013
|
Invention
|
Method for administering an nmda receptor antagonist to a subject. Compositions and methods for a... |
|
2012
|
Invention
|
Compositions for the treatment of cns-related conditions. The invention provides compositions com... |
|
|
Invention
|
Method for administering an nmda receptor antagonist to a subject. The invention provides methods... |
|
|
Invention
|
Methods for the treatment of cns-related conditions. The invention provides methods for administe... |
|
|
Invention
|
Composition for administering an nmda receptor antagonist to a subject. The invention provides co... |
|
2010
|
Invention
|
Method and composition for administering an nmda receptor antagonist to a subject. The invention ... |
